显示标签为“tumor”的博文。显示所有博文
显示标签为“tumor”的博文。显示所有博文

2016年5月27日星期五

Efficient photothermal tumor treatment based by heat shock protein developed by Chinese scientists

Professor Zhou Jingfu at Capital Normal University made use of new-type soft template synthesis method to synthesize rare-earth conversion luminescent nanomaterials with a porous structure, and they took it as a vector between small molecule photothermal conversion material cypate and heat shock protein siRNA. By interfering with the synthesis of heat shock protein, they achieved an efficient photothermal tumor therapy of multi-mode imaging guidance, providing a new idea for increasing the depth of treatment, improving the therapeutic effect and reducing the side effects of treatment.

Heat shock proteins are a class of heat-related proteins which exist widely in all living organisms, from bacteria to humans. Heat shock proteins (HSP) are a family of proteins that are produced by cells in response to exposure to stressful conditions. When the organisms are exposed to high temperature, they will synthesize such protein to protect themselves. Thus, inhibiting synthesis of heat shock protein can reduce the heat resistance of tumor cells so as to enhance the effectiveness of photothermal tumor treatment and reduce the temperature of treatment required. In addition, by visualization means of multimode imaging can they effectively locate the tumor, further enhancing the photothermal efficacy and safety.

The findings were published in the journal Adv. Funct. Mater. More information about protein can be found in Cusabio which is a company specialized in the production and sales of recombinant proteins and antibodies. Feel free to contact Cusabio.

Feel free to visit www.cusabio.com if you like the content above.

2016年5月11日星期三

Scientists achieve accurate positioning of tumor tissue

Fluorescent dyes biometrics in the biomedical field has a very broad application prospects, particularly special fluorescence identifying and fluorescence imaging have the characteristics of being fast, safe, efficient and non-invasive, are ideal for the early diagnosis and guide treatment of diseases in organizations or in vivo.

Recently, Zhu Weihong research group at College of Chemistry, East China University of Science and Technology achieved recognition in the near-infrared fluorescent dye research important progress, the successful implementation of β- galactosidase real-time in vivo and in situ detection, and access to the high-resolution three-dimensional in vivo imaging signal, the tumor tissue of precise positioning. Relevant research results are published as "Real-Time Tracking and in Vivo Visualization ofβ-Galactosidase Activity in Colorectal tumor with a Ratiometric Near-Infrared Fluorescent Probe" online in American chemical Society. The work is mainly done by doctoral Gukai Zhi Guo and former Associate Professor, and has been ably assisted Biological Engineering Professor Shi Ping.

β- galactosidase is an important marker of cell aging process and primary ovarian cancer and other related diseases and benzopyran nitrile group is a near-infrared fluorescent dye signal group. The group skillfully constructed of β- galactosidase specific recognition rate of near-infrared fluorescence probes detection performance β- galactosidase when ratio and enhanced near infrared signal in response to the two modes, successfully achieving quantitative detection in living cells by endogenous β - galactosidase. They used near-infrared specificity and high-sensitivity fluorescence signal to achieve precise positioning of tumor tissues with β- galactosidase overexpression.

Go through this link: http://www.cusabio.com/Recombinant-Protein/Recombinant-Lophura-leucomelanos-Kalij-pheasant-Lysozyme-C-11106406.html

2016年5月5日星期四

Curves along edge of tumor play an important role in the activation of cancer cells

According to a recent study of University of Illinois in the United States, among malignant tumors, only a few tumor cells can escape and spread to other parts of the body. However, curves along the edge of the tumor may play an important role in the activation of these cells.

Use in a variety of shapes and patterns designed organizational environment, the skin cancer study found that the more curved cell cultures, at the edge of the display there are more cancer stem cell marker characteristics - it is spreading to other key organizations. This is for us to learn more about cancer and the development of personalized treatment programs has a profound effect.

The study, by a professor of materials science and engineering and professor of veterinary Kristopher Kilian Timothy Fan complete guide, published in the latest issue of the journal Nature Materials.

Kilian said, "Cancer metastasis is the most dangerous place. Some we call cancer stem cells, can be deadly performance, they can be reached through the bloodstream to other tissues and form new tumors. Now we need some way to these cells are found and understand them, and it is important, given the development of new drugs to target them because these cancer stem cells to targeted primary tumor chemotherapy drugs produce drug resistance, which can lead to cancer recurrence."

Kilian's team specializes in tissue engineering to create tumor models to more accurately study the cancer process in a petri dish in. In the new study, the researchers cultured in a variety of different shapes and patterns 2 d and 3 d environment mouse skin cancer cell colonies, to explore whether the shape of the tumor helps activate the cancer stem cells, cancer stem cells and to explore which appeared in the tumor site.

They found that most of the cancer stem cells appear to be designed at the edge of the tumor environment, particularly in the angular and convex curve place. Kilian said, "It is very strange to normal stem cells prefer soft, slimy internal position so cancers, everyone agrees that cancer stem cells in the middle of the tumor, we found that the geometric constraints - like tumors. Healthy tissue in contact with the site, it seems to activate these cancer stem cells at the edges."

Researchers in their engineering environment have done a lot of testing to confirm the ability of tumor spread, such as genetic analysis. They also tested other cancer cell lines - human cervical cancer, lung cancer and prostate cancer, and found them in the same way there is a pattern of the tumor environment responded.

Then, Kilian's team in collaboration with Fan's team tested skin cancer stem cells in live mice, they found that, compared with the traditional dish, from the culture environment have a pattern of cells, are more likely to cause cancer.

Kilian said, "We found that when the cells are designed to have characteristics of these stem cells, when transplanted into mice, the mice developed more tumors, their incidence of lung tumor metastases is much higher. The same in a tumor, this area developed into shape, you may activate the cells, then the cells to escape and form more tumors. This may help the surgeon to view the growth of the tumor periphery, and use them to guide the shape of the tumor, may be more uncertain for the site to assess, which means that they may need to remove more tissue surrounding the tumor, they may not need to take so many organizations."

Kilian hope, bring a patterned tissue engineering environment, will give researchers a new way to find cancer stem cells and cultured in conventional medium which has been very elusive - less than 1% of the cells be found. In addition to basic scientific discovery and understanding of these tumor cells, he also believes that the engineering design of the tumor environment in personalized medicine will have great therapeutic applications.

He said, "You can imagine, each patient has a particular cancer. You can design it in a dish, using the patient's own cells, you can develop a specific tumor models to test drugs. If you can take out the patient's cells and within a few days to get used to screen all available drugs micro tumors, the oncologist can give patients to develop individualized treatment programs, targeted at present we do not see the tumor cells and these elusive cancer stem cells."

Kilian said, "Although there is much work to be done, but we are very excited that that tumor growth in very simple material properties may be a culprit in the spread of the disease. We believe that it opens up for the development of the study drug a new way, and be able to guide the surgery, as well as understand the development and spread of cancer. Cancer is very complex, so put it in the background is the key. If a micro-environment provides the background which activates the spread of cancer cells, then it is quite important to understand this background."

Read more: http://www.cusabio.com/Recombinant-Protein/Recombinant-Rattus-norvegicus-Rat-Transforming-growth-factor-beta-1-11106403.html

2016年3月30日星期三

The new progress of the liquid biopsy technology

High-throughput sequencing of Circulating tumor DNA (ctDNA) is expected to achieve a personalized cancer treatment. However, the cell-free DNA (cfDNA) in blood is limited, limiting the analytical sensitivity. To this end, researchers at Stanford University have developed a method for correcting errors can be detected frequencies as low as 0.004% of the mutant allele.

In the study published in the journal Nature Biotechnology on Monday, the researchers introduced the approach called integrated digital error suppression (IDES). It is based on the Stanford team developed before a ctDNA detection technology called CAPP-seq, and it has been acquired by Roche.

Previously, the limit of detection CAPP-seq technology is 0.02%, but many have the wrong sequencing fragments. To resolve these errors, the research team first devised a molecular barcodes strategy. Many ctDNA detection developers also use this program to reduce the error rate. Single-stranded DNA and double-stranded DNA barcodes strategies exist, but there are drawbacks. Double-stranded DNA barcodes in reducing errors on better, but less efficient than single-stranded DNA barcoding is therefore not suitable ctDNA limited amount of samples.

To this end, they set out to design a hybrid strategy. First, they devised sequencing connector that can be used for molecular barcodes of single and double stranded. Each strand of the double-stranded molecule of the first four-base mark a bar code, bar code called an index. Then they add two dinucleotide barcode on each of the two strands of the joint, called an insertion bar code. After sequencing, the bar code can be inserted into a complementary match to reconstruct the original double-stranded DNA molecule.

The second step, the Stanford team designed a computational tool that can correct sequencing or PCR system error. To achieve this, they first samples of 12 healthy adults carry CAPP-seq detection. The researchers reported that, despite all kinds of SNV has a background error, but the most common is a G → T transversion, and the error C → T and G → A also has.

They found that, G → T error occurs because the Hybrid Capture Process oxidative damage. They used a computational method to suppress these errors. The combination of these two strategies, so that the error rate has dropped by 15 times, which is by 30 healthy control samples and 142 samples of non-small cell lung cancer confirmed.

Researchers are also NSCLS samples on this verification test. First, they examined 41 patients with advanced NSCLS EGFR mutation hotspot. They detected 88 plasma samples to 412 EGFR mutation, all variations have been confirmed by a tumor biopsy sample. In addition, this test did not check out any false positives.

They then assessed the technical limitations in the detection of the reference cell lines. They created a reference cell lines mixture, wherein the frequency of allelic variation at 0.05-1.6%. They found that the bar code policy and calculation methods are complementary correction, combined with better results. Theoretical detection limit of this method is 0.00025%.

Finally, they used this method to monitor the 30 NSCLC patients with mutations; these patients have had tumor genotyping. The researchers found that they could detect the mutation frequency as low as 0.004%. "To our knowledge, this is the minimum amount of ctDNA with deep sequencing detection by far," the authors wrote.

See more: http://www.cusabio.com/Polyclonal-Antibody/SIRP-%CE%B11%CE%B21-Polyclonal-Antibody-11106177.html

2016年3月22日星期二

How does RNA editing promote the growth of tumors?

Recently a new study provides new insights for the role which RNA (ribonucleic acid) may play in cancer. The study was published in the journal Scientific Reports, allowing us to learn more about a new mechanism involved in tumor development and progression, and thus may lead to better treatment in the future.

In every healthy human cell, the genetic information connected to DNA is transcribed into messenger RNA and then translated into proteins - important component of all the body tissues and organs. Popular view is that the majority of malignant tumors are caused by mutations in the DNA, which can lead to abnormal activation of the corresponding protein abnormal activation or inactivation, leading to malignant cell growth and uncontrolled proliferation. RNA editing - through this process RNA sequence "mutate" in the transcript after the introduction and it is possible to affect a variety of cellular processes. But the exact mechanism is still unclear.

Previous studies have shown that there are more than one million sites in the genome edited in varying degrees. Although most of these sites belong to the area where proteins are not translated. But according to proof, the difference between RNA editing level tumors and normal tissue is related to the different clinical outcomes. Currently, only a few coding RNA editing site functionality has been characterized. However, whether and how the non-coding region of RNA editing in most things they affect tumor growth, remains a mystery.

In this study, researchers from Boston University School of Medicine (BUSM), analyzed 14 types of cancer, and identified over 2000 genes, RNA editing levels between tumor and normal tissues showed significant change.

The corresponding author, associate professor of medicine BUSM Stefano Monti explained, "This study shows that RNA editing can serve as an important cellular regulation of epigenetic mechanisms beyond genetics / DNA level. An epigenetic effect of components can be offset by change in another genetic component. Therefore, it is very important to have a comprehensive understanding in the change of cancer genomics. Loopholes of appropriate targeted therapy may be found."

Read more: http://www.cusabio.com/Polyclonal-Antibody/SLC34A2-Antibody-FITC-conjugated--11106194.html

2016年3月15日星期二

New antitumor immune pathway can help mammals fight against the virus' carcinogenic function

Researchers Southwestern Medical Center University of Texas identified a new pathway of innate immunity which can help mammals resist against carcinogenic virus. The study was recently published in the journal PNAS.

Virus-related cancer is actually quite common, "over 20% of human cancers and chronic viral infections," first author Dr. Xiaonan Dong said. Dr. Dong graduated from Tsinghua University seeks to reveal the host - pathogen interaction of molecular mechanisms, in particular autophagy in innate immunity role.

Autophagy is a fairly conservative process, cell by autophagy to clear damaged proteins and organelles. Studies have shown that autophagy-related protein beclin 2 can promote the decomposition of oncogenic viral proteins, inhibit cancer and viral infections caused.

Improve beclin 2 expression, Kaposi sarcoma-associated herpes virus G protein-coupled receptor (GPCR) degrade rapidly, reducing signal transduction promote tumorigenesis. Reduce beclin 2 expression, GPCR virus persists, promote tumorigenesis. This response is part of the endosomal lysosomal transport, and bacterial protein is fed to the lysosome through this process.

"We have a better understanding of the immune system against cancer-causing virus mechanism," who led the study, Professor Dr. Beth Levine said. "Help identify new therapeutic targets and develop new anti-viral therapy."

EB virus (EBV) is a ubiquitous herpesvirus type 4, is closely associated with many tumors, including Burkitt's lymphoma, Hodgkin's lymphoma, stomach cancer, nasopharyngeal carcinoma, and so on. According to statistics, more than 90% of the adult body have lurked virus. EBV infected B cells process has been studied extensively, but it is the mechanism of EBV infection of epithelial cells is still poorly understood. Sun Yat-sen Cancer Center and Harvard Medical School research team found that, NMHC-IIA nasopharyngeal epithelial cells is an important factor-mediated EBV infection.

HPV is one of the most common sexually transmitted viruses and HPV-induced head and neck cancer is increasing year by year. People need to understand molecular changes HPV-positive head and neck cancer, and the development of new therapeutic strategies based on this. Nature magazine published by far the most comprehensive head and neck cancer genome sequencing analysis. Cancer Genome Atlas Program (Cancer Genome Atlas, TCGA) scientists revealed the human papillomavirus (HPV) and the impact of smoking on the head and neck cancer, head and neck cancer compared with other cancers of the similarities and differences, for the diagnosis and treatment of head and neck cancer provided new direction.

Cervical cancer is the second leading cause of cancer in women, especially common in developing countries, where early screening is not common. It found that almost all cervical cancer is the human papillomavirus (HPV) infection. Scientists have long thought that estrogen is the main factor driving the growth of cancer. However, a study published in the journal PNAS shows that the estrogen receptors in cancer cells almost all disappear.

More can be found here: http://www.cusabio.com/ELISA-Kit/Bovine-C-telopeptide-of-type-%E2%85%A1-collagenCTX-%E2%85%A1-ELISA-Kit-1035497.html